Page last updated: 2024-11-02

oxybutynin and Hidradenitis Suppurativa

oxybutynin has been researched along with Hidradenitis Suppurativa in 2 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Hidradenitis Suppurativa: A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Molinelli, E1
D'Agostino, GM1
Sapigni, C1
Gioacchini, H1
Brisigotti, V1
Rizzetto, G1
Offidani, A1
Simonetti, O1
Ardon, CB1
Wang, C1
Prens, EP1
van Straalen, KR1

Other Studies

2 other studies available for oxybutynin and Hidradenitis Suppurativa

ArticleYear
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2023, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; Hidradenitis Suppurativa; Humans; Mandelic Acids; Prospective Studies

2023
Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches.
    The British journal of dermatology, 2021, Volume: 184, Issue:2

    Topics: Cytokines; Hidradenitis Suppurativa; Humans; Pore Forming Cytotoxic Proteins; Severity of Illness In

2021